Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.86
+5.00 (2.44%)
AAPL  263.80
+3.22 (1.24%)
AMD  199.89
-3.48 (-1.71%)
BAC  53.01
+0.24 (0.46%)
GOOG  315.70
+12.14 (4.00%)
META  655.55
+10.77 (1.67%)
MSFT  397.66
-0.80 (-0.20%)
NVDA  189.91
+2.01 (1.07%)
ORCL  148.41
-8.13 (-5.19%)
TSLA  411.21
-0.50 (-0.12%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.